会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • METHOD FOR DRUG DELIVERY TO OCULAR TISSUE USING MICRONEEDLE
    • 使用MICRONEEDLE将药物递送至眼用组织的方法
    • WO2007131050A2
    • 2007-11-15
    • PCT/US2007/068055
    • 2007-05-02
    • GEORGIA TECH RESEARCH CORPORATIONEMORY UNIVERSITYPRAUSNITZ, Mark, R.JIANG, NinghaoEDELHAUSER, Henry, F.
    • PRAUSNITZ, Mark, R.JIANG, NinghaoEDELHAUSER, Henry, F.
    • A61F9/00
    • A61F9/0017A61M2037/0061
    • Methods and devices are provided for administering a drug to a patient's eye. The methods include (a) inserting a hollow microneedle into the sclera or corneal stroma without penetrating across the sclera or corneal stroma; and (b) infusing a fluid drug formulation through the microneedle and into the sclera or cornea. It further may include partially retracting the microneedle before infusion to enhance delivery. Alternatively, the methods may include (a) inserting a solid microneedle into the sclera or corneal stroma without penetrating across the sclera or corneal stroma, wherein the solid microneedle comprises a first quantity of a drug formulation and inserting causes the solid microneedle to form a pocket in the sclera or corneal stroma; and (b) releasing the drug formulation into the pocket to form a drug depot, whereby a drug is released from the depot. The methods and devices may include an array of multiple microneedles.
    • 提供了用于向患者的眼睛施用药物的方法和装置。 所述方法包括(a)将中空微针插入巩膜或角膜基质中而不穿透巩膜或角膜基质; 和(b)将流体药物制剂通过微针注入巩膜或角膜。 它还可以包括在输注之前部分缩回微针以增强递送。 或者,所述方法可以包括(a)将固体微针插入巩膜或角膜基质中而不穿透巩膜或角膜基质,其中所述固体微针包含第一量的药物制剂并且插入导致固体微针形成口袋 在巩膜或角膜基质中; 和(b)将药物制剂释放到口袋中以形成药物库,由此从药剂库释放药物。 所述方法和装置可以包括多个微针的阵列。